Safety and Effectiveness of Capivasertib with Fulvestrant in Patients with Advanced Breast Cancer and Diabetes – a Multi-country Observational Study using Secondary Real-World Data (CAPIseid)

17/12/2025
17/12/2025
EU PAS number:
EUPAS1000000805
Study
Planned
Documents
Study protocol
Initial protocol
English (3.17 MB - PDF) View document
Study results
Study report
Other information